Want to join the conversation?
Goldman Sachs analyst Jami Rubin questions if $MYL will implement its share buyback now that the pending deal is closed. $MYL says that share buyback is back on the table as an option, but the priority is to delever and making sure to balance it out. The company is absolutely committed to $6.18.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?